Symptomatic lobar intracerebral hemorrhage during extended lecanemab treatment: A case report. (PubMed, J Alzheimers Dis Rep) - Oct 16, 2026 - "MRI revealed a 2.5-cm left parietal subcortical hemorrhage. This case highlights that symptomatic lobar hemorrhage may occur even during extended lecanemab therapy, underscoring the importance of continued safety monitoring during extended treatment."
Journal • Alzheimer's Disease • Cerebral Hemorrhage • CNS Disorders • Hematological Disorders
|
|
Akihiro Tsukahara; Etsuro Mori; Hiroo Yoshikawa; Naoyuki Shiraishi; Takashi Uzu; Takuya Nishina; Yugo Takahashi; Yukari Matsuda
|